KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Equity (2016 - 2025)

Historic Return on Equity for Eli Lilly (LLY) over the last 16 years, with Q4 2025 value amounting to 0.82%.

  • Eli Lilly's Return on Equity rose 800.0% to 0.82% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.82%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 1.01% for FY2025, which is 1700.0% up from last year.
  • Eli Lilly's Return on Equity amounted to 0.82% in Q4 2025, which was up 800.0% from 0.87% recorded in Q3 2025.
  • Eli Lilly's Return on Equity's 5-year high stood at 0.87% during Q3 2025, with a 5-year trough of 0.21% in Q1 2021.
  • In the last 5 years, Eli Lilly's Return on Equity had a median value of 0.6% in 2022 and averaged 0.6%.
  • In the last 5 years, Eli Lilly's Return on Equity skyrocketed by 4500bps in 2022 and then plummeted by -2000bps in 2023.
  • Over the past 5 years, Eli Lilly's Return on Equity (Quarter) stood at 0.65% in 2021, then fell by -9bps to 0.6% in 2022, then decreased by -21bps to 0.47% in 2023, then skyrocketed by 57bps to 0.74% in 2024, then grew by 11bps to 0.82% in 2025.
  • Its Return on Equity was 0.82% in Q4 2025, compared to 0.87% in Q3 2025 and 0.81% in Q2 2025.